← Back to Clinical Trials
Recruiting NCT07523906

NCT07523906 Effects of Lumbar Stabilization Exercises Versus Muscular Chain Therapy in Patients With Mechanical Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07523906
Status Recruiting
Phase
Sponsor Ibadat International University, Islamabad
Condition Low Back Pain, Mechanical
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-02-04
Primary Completion 2026-05-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Lumbar Stabilization ExercisesMuscular Chain Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-02-04 with a primary completion date of 2026-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled trial is to compare the effectiveness of lumbar stabilization exercises and muscular chain therapy on reducing pain intensity and functional disability in patients with mechanical CLBP. * Participants will be randomly assigned to two groups: * Group A: Lumbar stabilization exercises * Group B: Muscular chain therapy (posterior sagittal muscle chain) Outcomes will be assessed at baseline and on week 6 to evaluate which exercise program is more effective in reducing pain and improving functional outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients aged between 18-30 years will be included in the study. * Participants must have a history of mechanical CLBP. * The pain must be localized to the lumbar region. * Participants must be able to perform physical activities and participate in exercise-based interventions. * Participants who have pain range \> 4 will be included in the study. Exclusion Criteria: * Patient with structural lesions, such as spondylolisthesis, stenosis, vertebral bone fracture, scoliosis and kyphosis on x-ray, will be excluded. * Pregnant females would be excluded. * Females with a history of neurological, infections, and systemic disease, including cerebrovascular disease, spondylitis, cancer, spinal cord disease, cauda equine, rheumatologic disorders. * Females who have undergone spinal surgery or any surgical intervention related to the lower back or pelvis will be excluded. * Lumbar radiculopathy will be excluded in the study.

Contact & Investigator

Central Contact

Inza Farooq, MS-PT(MSK)*

✉ inzafarooq9@gmail.com

📞 00923115392269

Principal Investigator

Muhammad Nazim Farooq, PhD-PT

PRINCIPAL INVESTIGATOR

Ibadat International University

Frequently Asked Questions

Who can join the NCT07523906 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Low Back Pain, Mechanical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07523906 currently recruiting?

Yes, NCT07523906 is actively recruiting participants. Contact the research team at inzafarooq9@gmail.com for enrollment information.

Where is the NCT07523906 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07523906 clinical trial?

NCT07523906 is sponsored by Ibadat International University, Islamabad. The principal investigator is Muhammad Nazim Farooq, PhD-PT at Ibadat International University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology